New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

By E. Eisenhauer, P. Therasse, J. Bogaerts, Lawrence H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney and 6 more. European Journal of Cancer, 2009

26,513 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/871ed6d95d395e93dce6e1cb05a39f498296c910

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

In Radiology, Nuclear Medicine and Imaging

In Statistics and Probability

Citations in the corpus

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. (2020, methodology): “CRPC is defined as castrate serum testosterone 50 ng/dl or 1.7 nmol/l plus one of the following types of progression: 1 Biochemical progression: three consecutive rises in PSA 1 wk apart, resulting in two 50% increases over the nadir, and PSA > 2 ng/mL 2 Radiological progression: the appearance of ”
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. (2013, background): “1.(13) A list of the EGFR mutations detectable by Therascreen and the full eligibility criteria are provided in the protocol.”
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010, background): “1.(10) However, given the heterogeneity of high-grade gliomas and the difficulty in measuring some lesions, a maximum of five of the largest lesions may be measured.”
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS) (2015, methodology): “…either based on qualitative criteria only (indicating, for example, the presence of characteristic hyper-intense tissue appearance in contrast-enhanced T1-weighted MRI), or by relying on such rudimentary quantitative measures as the largest diameter visible from axial images of the lesion [4], [5].”
Standards for PET Image Acquisition and Quantitative Data Analysis (2009, background): “The main disadvantage of nonstandardized SUVs is that, although a proof of concept for various clinical applications has been demonstrated in several single-center studies, the results cannot be directly applied at other sites or in multicenter studies(45).Suchheterogeneitypartlyexplainswhyeventhe l”
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023, positive): “[309] mRECIST criteria has been proposed to adapt RECIST criteria to particularities of HCC, enabling capture of antitumoral response without observed shrinkage after local and systemic therapies.”